Vertex Pharmaceuticals Incorporated shares owned by Schonfeld Strategic Advisors
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Schonfeld Strategic Advisors
from 13F filings
Historical chart of Schonfeld Strategic Advisors investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Schonfeld Strategic Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $1.2M | 2.4k | 484.82 |
| 2024-12-31 | $3.0M | 7.4k | 402.70 |
| 2024-09-30 | $33M | 71k | 465.08 |
| 2024-06-30 | $18M | 38k | 468.72 |
| 2024-03-31 | $17M | 42k | 418.01 |
| 2023-09-30 | $15M | 42k | 347.74 |
| 2023-06-30 | $24M | 69k | 351.91 |
| 2023-03-31 | $23M | 72k | 315.07 |
| 2022-12-31 | $2.1M | 7.2k | 288.78 |
| 2022-09-30 | $4.4M | 15k | 289.51 |
| 2021-12-31 | $2.0M | 9.1k | 219.56 |
| 2021-09-30 | $5.5M | 31k | 181.39 |
| 2021-06-30 | $3.0M | 15k | 201.60 |
| 2021-03-31 | $8.0M | 37k | 214.87 |
| 2020-12-31 | $5.4M | 23k | 236.34 |
| 2020-09-30 | $2.0k | 5.8k | 0.34 |
| 2020-06-30 | $1.4M | 4.7k | 290.34 |
| 2020-03-31 | $869k | 3.7k | 238.08 |
| 2019-12-31 | $1.8M | 8.2k | 219.05 |
| 2019-09-30 | $5.4M | 32k | 169.44 |
| 2019-06-30 | $3.0M | 17k | 183.37 |
| 2019-03-31 | $3.6M | 19k | 183.97 |
| 2018-12-31 | $7.7M | 46k | 165.72 |
| 2018-09-30 | $4.6M | 24k | 192.73 |
| 2018-03-31 | $1.1M | 6.5k | 162.90 |
| 2017-12-31 | $695k | 4.6k | 149.85 |
| 2017-09-30 | $5.4M | 35k | 152.03 |
| 2017-06-30 | $288k | 2.2k | 128.86 |
| 2017-03-31 | $4.9M | 45k | 109.34 |
| 2016-12-31 | $1.5M | 20k | 73.65 |
| 2016-03-31 | $1.2M | 15k | 79.47 |
More positions owned by Schonfeld Strategic Advisors
View all positions for Schonfeld Strategic Advisors
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated